Ferring, Aventis Reach $20M Deal In DDAVP Antitrust Suit
Ferring BV and Aventis Pharmaceuticals Inc. on Wednesday agreed to pay $20.25 million to settle with a proposed class of direct purchasers of DDAVP who claimed in a New York suit...To view the full article, register now.
Already a subscriber? Click here to view full article